| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
5ß1 Integrin Receptor in the Proliferative Response of Quiescent Human Melanoma Cells to Fibronectin1
Division of Experimental Oncology D, Istituto Nazionale Tumori, Milan [R. M., G. P., A. A.]; Laboratory of Experimental Medicine, Università La Sapienza, Rome [A. G., A. S.]; and Laboratory of Pathophysiology, Regina Elena Cancer Institute, Rome [A. S.], Italy
The possible mitogenic activity of fibronectin (FN) in human primary and metastatic melanoma lines and clones and the involvement of integrins in mediating this effect were evaluated. Quiescent human melanoma cells cultured in serum-free medium proliferated in a dose- and time-dependent fashion to immobilized FN as indicated by [3H]thymidine incorporation, increment of cell number, and cell cycle analysis. This response to FN was observed with tumor clones isolated from a subcutaneous metastasis and with primary or metastatic melanomas from different patients, but only when tumor cells expressed the
5 subunit of the FN receptor (i.e., VLA-5). Proliferation to FN by a primary tumor (Me4405) expressing all FN receptors and by a tumor clone (2/60) lacking only the
4 subunit was inhibited by monoclonal antibodies to the
5 and ß1 but not by monoclonal antibodies to other subunits of FN receptors. Mapping of FN regions responsible for the proliferative signal was performed by stimulating melanoma cells with different FN proteolytic fragments and indicated that a significant mitogenic signal was provided by the Mr 120,000
-chymotrypsin fragment containing the Arg-Gly-Asp sequence. The proliferation of melanoma cells to FN and to FN fragments was also significantly inhibited by peptides containing the Arg-Gly-Asp sequence. These data indicate that FN can stimulate the proliferation of quiescent melanoma cells and that integrins as
5ß1 are involved in the response of tumor cells to this extracellular matrix protein.
1 Supported in part by the Italian Association for Cancer Research, Milan, Italy.
2 To whom requests for reprints should be addressed, at Division of Experimental Oncology D, Istituto Nazionale Tumori, Via Venezian 1, 20133 Milan, Italy.
Received 3/ 2/92. Accepted 6/ 8/92.
This article has been cited by other articles:
![]() |
M. Illario, A. L. Cavallo, S. Monaco, E. Di Vito, F. Mueller, L. A. Marzano, G. Troncone, G. Fenzi, G. Rossi, and M. Vitale Fibronectin-Induced Proliferation in Thyroid Cells Is Mediated by {alpha}v{beta}3 Integrin through Ras/Raf-1/MEK/ERK and Calcium/CaMKII Signals J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2865 - 2873. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Aguirre-Ghiso, D. Liu, A. Mignatti, K. Kovalski, and L. Ossowski Urokinase Receptor and Fibronectin Regulate the ERKMAPK to p38MAPK Activity Ratios That Determine Carcinoma Cell Proliferation or Dormancy In Vivo Mol. Biol. Cell, April 1, 2001; 12(4): 863 - 879. [Abstract] [Full Text] |
||||
![]() |
R. I. LINNOILA, E. SZABO, F. DEMAYO, H. WITSCHI, C. SABOURIN, and A. MALKINSON The Role of CC10 in Pulmonary Carcinogenesis: From a Marker to Tumor Suppression Ann. N.Y. Acad. Sci., December 1, 2000; 923(1): 249 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Kelynack, T. D. Hewitson, K. M. Nicholls, I. A. Darby, and G. J. Becker Human renal fibroblast contraction of collagen I lattices is an integrin-mediated process Nephrol. Dial. Transplant., November 1, 2000; 15(11): 1766 - 1772. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Aguirre Ghiso, K. Kovalski, and L. Ossowski Tumor Dormancy Induced by Downregulation of Urokinase Receptor in Human Carcinoma Involves Integrin and MAPK Signaling J. Cell Biol., October 4, 1999; 147(1): 89 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vitale, T. Di Matola, G. Fenzi, M. Illario, and G. Rossi Fibronectin Is Required to Prevent Thyroid Cell Apoptosis through an Integrin-Mediated Adhesion Mechanism J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3673 - 3680. [Abstract] [Full Text] |
||||
![]() |
A. Astier, S. N. Manie, H. Avraham, H. Hirai, S. F. Law, Y. Zhang, E. A. Golemis, Y. Fu, B. J. Druker, N. Haghayeghi, et al. The Related Adhesion Focal Tyrosine Kinase Differentially Phosphorylates p130Cas and the Cas-like Protein, p105HEF1 J. Biol. Chem., August 8, 1997; 272(32): 19719 - 19724. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Coopersmith, C. Chandrasekaran, M. S. McNevin, and J. I. Gordon Bi-transgenic Mice Reveal that K-rasVal12 Augments a p53-independent Apoptosis When Small Intestinal Villus Enterocytes Reenter the Cell Cycle J. Cell Biol., July 14, 1997; 138(1): 167 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vitale, M. Illario, T. Di Matola, A. Casamassima, G. Fenzi, and G. Rossi Integrin Binding to Immobilized Collagen and Fibronectin Stimulates the Proliferation of Human Thyroid Cells in Culture Endocrinology, April 1, 1997; 138(4): 1642 - 1648. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |